✦ LIBER ✦

6503 ORAL Efficacy and safety results from BO17704, a randomised, placebo-controlled phase III study of bevacizumab in combination with cisplatin and gemcitabine in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC)

✍ Scribed by Manegold, C.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; Hirsh, V.; Leighl, N.; Mezger, J.; Moore, N.; Reck, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6509 ORAL Management of hypertension (HT

✍ Bennouna, J.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V.; Hirsh, V. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

6518 ORAL Subgroup results from a random

✍ Eberhardt, W.; Reck, M.; vonPawel, J.; Zatloukal, P.; Ramlau, R.; Gorbounova, V. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

9003 ORAL Biomarker Analysis in BO21015,

✍ Mok, T.; Gorbunova, V.; Juhasz, E.; Szima, B.; Burdaeva, O.; Yu, C.J.; Delmar, P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

PCN14 AN INDIRECT COMPARISON OF THE EFFI

✍ S Walzer; J de Castro Carpeño; A Vergnenegre; C Chouaid; D Heigener; HG Bischoff 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Efficacy of bevacizumab with cisplatin a

✍ Tony SK MOK; Te-Chun HSIA; Chun-Ming TSAI; Kenneth TSANG; Gee-Chen CHANG; John W 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

9170 Safety and efficacy of first-line b

✍ Garrido, P.; Thatcher, N.; Crino, L.; Dansin, E.; Laskin, J.; Pavlakis, N.; Tsai 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB